ENVitiligo treatment in Germany aims to stop white patches from spreading and to bring colour back. The patches appear because pigment cells in the skin stop working. The condition is not contagious or dangerous to health in itself, but it is very visible and often a heavy emotional burden. Treatment can restore colour to many areas, especially the face, but repigmentation is slow and not guaranteed.
Below: the forms of vitiligo, how activity is assessed, creams, light and surgery, everyday help and how AlenMed organises treatment.
What Vitiligo Is
Vitiligo is a long-term disease in which the immune system attacks the skin’s pigment cells, the melanocytes, leaving white patches. An inherited tendency involving many genes plays a role, and skin injury or friction, sunburn and stress can trigger or worsen it.
There are two main forms. Non-segmental vitiligo, the common one, causes symmetrical patches on both sides of the body and has an unpredictable course. Segmental vitiligo affects one area on one side, often starts in childhood and frequently stops spreading by itself after a year or two. Other autoimmune diseases, above all of the thyroid, are more frequent with vitiligo, so thyroid disease treatment is sometimes needed too.
Examination and Assessment of Activity
The key question is whether the disease is active or stable, because this decides the treatment. Under a Wood’s lamp, ultraviolet light makes pale patches stand out, especially in fair skin. Photos are taken for later comparison, and the doctor asks about new or growing patches in recent months. Clusters of tiny spots and new patches where the skin was scratched or rubbed also signal activity.
Blood tests usually cover TSH, which reflects thyroid function, and thyroid antibodies; other autoimmune markers are checked only if symptoms or earlier results suggest them. A biopsy is rarely needed, mainly when the diagnosis is in doubt. Light patches left by a fungal infection (pityriasis versicolor) or by skin inflammation must also be told apart.
Vitiligo Treatment Options in Germany
Treatment uses creams, light and, if the disease spreads fast, tablets; small areas usually start with creams. Corticosteroid creams calm inflammation and are used for limited periods, for example two weeks on, two weeks off. On the face, neck and skin folds, where strong steroids can thin the skin, the calcineurin inhibitors tacrolimus or pimecrolimus are preferred: they dampen inflammation and help pigment cells move in, though their use in vitiligo is off-label. Ruxolitinib cream, a JAK inhibitor, is approved in the EU for non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. It blocks JAK1 and JAK2, enzymes used by interferon gamma, which is thought to drive the immune attack, so melanocytes can make pigment again.
The second pillar is light therapy, or phototherapy. Narrowband UVB at 311 nm calms the immune attack and activates reserve pigment cells in the hair follicles. Sessions run two to three times a week, results are reviewed every three months, and a course lasts at least six months, since colour can take months to start returning. Small patches can be targeted with an excimer lamp or laser at 308 nm. The face and neck respond best, the hands and feet worst: pigment returns mainly from hair follicles, which are scarce there. A recent review in the German Dermatological Society’s journal details the methods and their timing.
If new patches appear fast, a systemic medicine can slow the process, usually corticosteroid tablets in short pulses on two consecutive days a week for several months. The dermatologist decides, weighing benefit against side effects.
Transplantation, Camouflage and Everyday Life
Transplantation suits only patches that have not changed for at least a year, most often in segmental vitiligo and usually after creams and light have failed. In melanocyte-keratinocyte transplantation, cells from a thin layer of the patient’s normal skin are spread onto the white patch as a suspension; alternatively, small skin grafts are used. Only specialised departments perform these procedures, results vary widely, and the final colour may take up to two years to appear.
Cover creams and self-tanners can camouflage the patches, though the shade may not match exactly. White patches burn easily and sunburn can trigger new ones, so use sunscreen with SPF 50 or higher and covering clothing in the sun. A psychologist or a self-help group helps many people. For other skin conditions, see dermatology in Germany.
Frequently asked questions
Can vitiligo be cured completely?
Not yet, but treatment can stop the spread and bring colour back to many areas, best on the face and neck and least on the hands and feet. Patches may return after treatment stops, so dermatologists sometimes keep a maintenance plan, for example tacrolimus ointment twice a week.
How long does vitiligo treatment take?
Months, not weeks. Phototherapy is planned for at least six months and continued while colour keeps returning. Calcineurin inhibitors are applied twice a day for at least 6–9 months, and the effect of ruxolitinib cream is judged after about a year. After transplantation, the final colour may take up to two years to appear.
Can I sunbathe if I have vitiligo?
It is better not to. White patches do not tan and burn easily, a sunburn can trigger new patches, and tanned skin makes the white areas stand out more. In the sun, use SPF 50 or higher and clothing that covers the patches. Therapeutic UV light means measured phototherapy under medical supervision.
Is vitiligo hereditary?
Only the tendency is inherited, not the disease itself, and many genes are involved. Vitiligo is more common in people whose relatives have it or who have other autoimmune diseases, but patches also need an immune disturbance and triggers such as skin injury, sunburn or stress. It is not contagious.
How AlenMed Organises Vitiligo Treatment in Germany
AlenMed starts with a remote assessment: photos of the patches, their recent history and previous treatments go in advance to a German dermatology department, which judges whether a visit makes sense. Phototherapy lasts months, so the plan is often set in Germany and continued at home. An existing plan can get a second opinion from German doctors. AlenMed’s partner hospitals include University Hospital Frankfurt, where Prof. Bastian Schilling is director of the Department of Dermatology, Venereology and Allergology.
The hospital prepares a cost estimate (Kostenvoranschlag); AlenMed books the appointment, helps with accommodation and arranges medical interpreters for consultations. The company office is in Munich; partner hospitals are across Germany.
This material is for reference only and is not an offer. The treatment is decided by a doctor at an in-person consultation.